speb/financial-data huggingface dataset:
Financial ratios for AEWU.L — annual report dated 2022-03-31
Total revenue: 70373684.21052632
Net income: 61440789.47368421
Capital expenditures: 0
Operating cash flow: 16217105.263157895
Net tangible assets: 251447368.42105263
Owner earnings: 61440789.47368421
Return on net tangible assets (%): 24.434850863422287
Buffett classification: The Gruesome
Stock price: 0.01131578947368421
P/E ratio: 0.029223745917121745
Shares outstanding: 158674746
Book value: 251447368.42105263
P/B ratio: 0.00714077873155416
Market cap (USD): 1795530.0205263156
Debt to equity: 0.2822815279958137
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.6247849824246503
Free cash flow (dilution-adjusted): 16217105.263157895
Buyback yield (%): 0
Receivables turnover: 7.17039817669929
Capitalized R&D asset: 0
FCF margin (%): 23.04427492334156
Rule of 40 score: 23.04427492334156
Financial ratios for AEWU.L — annual report dated 2023-03-31
Total revenue: -3560493.8271604935
Net income: -13981481.481481481
Capital expenditures: 0
Operating cash flow: 12123456.790123455
Net tangible assets: 206297530.86419752
Owner earnings: -13981481.481481481
Return on net tangible assets (%): -6.777338256503553
Buffett classification: The Gruesome
Stock price: 0.008765432098765432
Shares outstanding: 158674746
Book value: 206297530.86419755
P/B ratio: 0.006741974593808534
Market cap (USD): 1390852.7118518518
Debt to equity: 0.3575083332834632
Free cash flow (dilution-adjusted): 12123456.790123455
Buyback yield (%): 0
Receivables turnover: -0.3534746905257997
Capitalized R&D asset: 0
Revenue growth (%): -105.05941086800159
Rule of 40 score: -105.05941086800159
Financial ratios for AEWU.L — annual report dated 2024-03-31
Total revenue: 23808860.75949367
Net income: 11453164.556962024
Capital expenditures: 0
Operating cash flow: 14843037.974683544
Net tangible assets: 206015189.8734177
Owner earnings: 11453164.556962024
Return on net tangible assets (%): 5.559378686590641
Buffett classification: The Gruesome
Stock price: 0.00911392405063291
P/E ratio: 0.12626637612732095
Shares outstanding: 158674746
Book value: 206015189.87341768
P/B ratio: 0.007019626002752654
Market cap (USD): 1446149.583797468
Debt to equity: 0.36773741643727886
Effective tax rate (%): 0.46204620462046203
COGS to revenue (%): 0
SG&A to revenue (%): 8.017438460311553
Free cash flow (dilution-adjusted): 14843037.974683544
Buyback yield (%): 0
Receivables turnover: 1.5629882000997175
Capitalized R&D asset: 0
FCF margin (%): 62.342495613801894
Rule of 40 score: 62.342495613801894
Financial ratios for AEWU.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 230348000
Buffett classification: The Gruesome
Stock price: 0.011466666666666667
Shares outstanding: 158674746
Book value: 230348000
P/B ratio: 0.007898789747686109
Market cap (USD): 1819470.4208
Debt to equity: 0.34675650175676226
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEWU.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 226549350.64935064
Buffett classification: The Gruesome
Stock price: 0.011948051948051947
Shares outstanding: 158674746
Book value: 226549350.64935064
P/B ratio: 0.008368393476379103
Market cap (USD): 1895854.108051948
Debt to equity: 0.3437225913335588
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEWU.L — annual report dated 2025-03-31
Total revenue: 40655844.15584415
Net income: 31615584.415584415
Capital expenditures: 0
Operating cash flow: 11228571.42857143
Net tangible assets: 226549350.64935064
Owner earnings: 31615584.415584415
Return on net tangible assets (%): 13.955274788899526
Buffett classification: The Gruesome
Stock price: 0.011948051948051947
P/E ratio: 0.059965809365757475
Shares outstanding: 158674746
Book value: 226549350.64935064
P/B ratio: 0.008368393476379103
Market cap (USD): 1895854.108051948
Debt to equity: 0.3437225913335588
Effective tax rate (%): 0.10668855149774314
COGS to revenue (%): 0
SG&A to revenue (%): 4.491295320236385
Free cash flow (dilution-adjusted): 11228571.42857143
Buyback yield (%): 0
Receivables turnover: 2.467097486011506
Capitalized R&D asset: 0
FCF margin (%): 27.618591279348355
Revenue growth (%): 70.75930077684555
Rule of 40 score: 98.3778920561939
Financial ratios for AEWU.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 233540540.54054055
Buffett classification: The Gruesome
Stock price: 0.013918918918918919
Shares outstanding: 158674746
Book value: 233540540.54054055
P/B ratio: 0.009456948754773754
Market cap (USD): 2208580.924054054
Debt to equity: 0.347268834625622
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALF.L — annual report dated 2021-06-30
Total revenue: 4117749
Net income: 3536820
Capital expenditures: 0
Operating cash flow: 1838984
Net tangible assets: 26054566
Owner earnings: 3536820
Return on net tangible assets (%): 13.57466480155532
Buffett classification: The Gruesome
Stock price: 0.0001388888888888889
P/E ratio: 0.0057391346605142465
Shares outstanding: 146147661
Book value: 26054566
P/B ratio: 0.000779068292674689
Market cap (USD): 20298.28625
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 14.107926442335364
Free cash flow (dilution-adjusted): 1838984
Buyback yield (%): 14448.943934860508
Retained earnings: -86206219
Capitalized R&D asset: 0
FCF margin (%): 44.65993434762537
Rule of 40 score: 44.65993434762537
Financial ratios for ALF.L — annual report dated 2022-06-30
Total revenue: -3111407
Net income: -5824052
Capital expenditures: 0
Operating cash flow: 2376044
Net tangible assets: 18030848
Owner earnings: -5824052
Return on net tangible assets (%): -32.300488584896286
Buffett classification: The Gruesome
Stock price: 0.00012195121951219514
Shares outstanding: 146147661
Book value: 18030848
P/B ratio: 0.000988466293310491
Market cap (USD): 17822.88548780488
Debt to equity: 0
Free cash flow (dilution-adjusted): 2376044
Buyback yield (%): 12341.806277693351
Retained earnings: -92030271
Capitalized R&D asset: 0
Revenue growth (%): -175.56087075729968
Rule of 40 score: -175.56087075729968
Financial ratios for ALF.L — annual report dated 2023-06-30
Total revenue: -3164138
Net income: -3255350
Capital expenditures: 0
Operating cash flow: 1562280
Net tangible assets: 12575833
Owner earnings: -3255350
Return on net tangible assets (%): -25.885760410463465
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 146147661
Book value: 12575833
P/B ratio: 0.0014710519711935292
Market cap (USD): 18499.703924050635
Debt to equity: 0
Free cash flow (dilution-adjusted): 1562280
Buyback yield (%): 11890.271374237045
Retained earnings: -95285621
Receivables turnover: -78.65902650027346
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALF.L — annual report dated 2024-06-30
Total revenue: -2405838
Net income: -2686758
Capital expenditures: 0
Operating cash flow: -698260
Net tangible assets: 9889075
Owner earnings: -2686758
Return on net tangible assets (%): -27.168951595573905
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 146147661
Book value: 9889075
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Free cash flow (dilution-adjusted): -698260
Retained earnings: -97972379
Receivables turnover: -45.390600532045354
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGN — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 108729000
Buffett classification: The Gruesome
Stock price: 657.18
Shares outstanding: 71618127
Market cap (USD): 47066000701.85999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGN — annual report dated 2022-12-31
Total revenue: 3734635000
Gross profit: 2633775000
Operating income: 654048000
Net income: 361573000
Capital expenditures: 291900000
Operating cash flow: 568732000
Depreciation & amortization: 125793000
Net tangible assets: 3098087000
Owner earnings: 195466000
Return on net tangible assets (%): 6.309248255455706
Capex to operating income (%): 44.62975194481139
Buffett classification: The Good
Stock price: 210.9
P/E ratio: 41.773757952889184
Shares outstanding: 71618127
Book value: 3601358000
P/B ratio: 4.194046519201923
Market cap (USD): 15104262984.300001
Debt to equity: 0.03523892931499729
Current ratio: 1.258843847016985
Quick ratio: 1.082949830389841
Effective tax rate (%): 39.64297220464831
COGS to revenue (%): 29.477043941375797
R&D to revenue (%): 8.173703722050481
SG&A to revenue (%): 44.836215587333164
Free cash flow (dilution-adjusted): 143465000
Buyback yield (%): 2.880219977977042
Retained earnings: 2566688000
Inventory turnover: 3.249752030984319
Receivables turnover: 3.7340039533318867
Capitalized R&D asset: 305258000
ROCI (R&D-adjusted, %): 19.817201632358273
FCF margin (%): 3.8414731292348514
Rule of 40 score: 3.8414731292348514
Financial ratios for ALGN — annual report dated 2023-12-31
Total revenue: 3862260000
Gross profit: 2706863000
Operating income: 656654000
Net income: 445053000
Capital expenditures: 177716000
Operating cash flow: 785776000
Depreciation & amortization: 142401000
Net tangible assets: 3128841000
Owner earnings: 409738000
Return on net tangible assets (%): 13.095520034415301
Capex to operating income (%): 27.063872298044327
Buffett classification: The Good
Stock price: 274
P/E ratio: 44.09220204784599
Shares outstanding: 71618127
Book value: 3630489000
P/B ratio: 5.405158037388352
Market cap (USD): 19623366798
Debt to equity: 0.03487656896908378
Current ratio: 1.1838793077168368
Quick ratio: 1.040213179935653
Effective tax rate (%): 30.591044347820663
COGS to revenue (%): 29.91504973771833
R&D to revenue (%): 8.97997545478554
SG&A to revenue (%): 44.103167575461
Free cash flow (dilution-adjusted): 454034000
Buyback yield (%): 3.018646117649765
Retained earnings: 2447174000
Inventory turnover: 3.891509656384935
Receivables turnover: 3.688347059452687
Capitalized R&D asset: 551352860
ROCI (R&D-adjusted, %): 17.20697999599234
Rosenberg metric: 0.23943025244219643
FCF margin (%): 11.755656014872121
Revenue growth (%): 3.417335295149325
Rule of 40 score: 15.172991310021446
Financial ratios for ALGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 254.32
Shares outstanding: 71618127
Market cap (USD): 18213922058.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 208.51
Shares outstanding: 71618127
Market cap (USD): 14933095660.769999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGN — annual report dated 2024-12-31
Total revenue: 3999012000
Gross profit: 2799159000
Operating income: 671764000
Net income: 421362000
Capital expenditures: 115580000
Operating cash flow: 738231000
Depreciation & amortization: 145034000
Net tangible assets: 3305867000
Owner earnings: 450816000
Return on net tangible assets (%): 13.636846249410517
Capex to operating income (%): 17.20544715108282
Buffett classification: The Great
Stock price: 208.51
P/E ratio: 35.44006260832728
Shares outstanding: 71618127
Book value: 3851985000
P/B ratio: 3.876727365441454
Market cap (USD): 14933095660.769999
Debt to equity: 0.03096507385153369
Current ratio: 1.2229676054340792
Quick ratio: 1.0981964419509653
Effective tax rate (%): 30.806179069526845
COGS to revenue (%): 30.003735922772922
R&D to revenue (%): 9.107299502977236
SG&A to revenue (%): 44.090715406705456
Free cash flow (dilution-adjusted): 448948000
Buyback yield (%): 2.363059930882439
Retained earnings: 2483766000
Inventory turnover: 4.718499176127761
Receivables turnover: 3.8836180566818133
Capitalized R&D asset: 697313240
ROCI (R&D-adjusted, %): 14.304861302357086
Rosenberg metric: 0.26611308133667794
FCF margin (%): 11.226472938815887
Revenue growth (%): 3.5407248605738606
Rule of 40 score: 14.767197799389747
Financial ratios for ALGN — quarterly report dated 2025-03-31
Total revenue: 979262000
Gross profit: 680108000
Operating income: 135278000
Net income: 93230000
Capital expenditures: 25289000
Operating cash flow: 52676000
Depreciation & amortization: 39148000
Net tangible assets: 3233882000
Owner earnings: 107089000
Return on net tangible assets (%): 3.311469002270336
Capex to operating income (%): 18.694096601073344
Buffett classification: The Great
Stock price: 158.86
P/E ratio: 30.508569278182993
Shares outstanding: 71618127
Book value: 3794243000
P/B ratio: 2.9985574606634313
Market cap (USD): 11377255655.220001
Debt to equity: 0.03124075079007855
Current ratio: 1.2064750058765974
Quick ratio: 1.0826309878510136
Effective tax rate (%): 33.61672434172114
COGS to revenue (%): 30.54892357714279
R&D to revenue (%): 9.925944231472272
SG&A to revenue (%): 45.71085164133807
Free cash flow (dilution-adjusted): -17610000
Buyback yield (%): 1.7674561079915503
Retained earnings: 2389252000
Inventory turnover: 1.21327671586222
Receivables turnover: 0.8941856048154398
Capitalized R&D asset: 97201000
ROCI (R&D-adjusted, %): 4.753509066406466
FCF margin (%): -1.7982930002389554
Rule of 40 score: -1.7982930002389554
Financial ratios for ALGN — quarterly report dated 2025-06-30
Total revenue: 1012449000
Gross profit: 708117000
Operating income: 163033000
Net income: 124608000
Capital expenditures: 21479000
Operating cash flow: 128650000
Depreciation & amortization: 40576000
Net tangible assets: 3318222000
Owner earnings: 143705000
Return on net tangible assets (%): 4.330783172433912
Capex to operating income (%): 13.17463335643704
Buffett classification: The Great
Stock price: 189.33
P/E ratio: 62.245613643670985
Shares outstanding: 71618127
Book value: 3912779000
P/B ratio: 3.4654295540100786
Market cap (USD): 13559459984.910002
Debt to equity: 0.03144056947760147
Current ratio: 1.2267997271838447
Quick ratio: 1.1046488494264295
Effective tax rate (%): 28.186449664584245
COGS to revenue (%): 30.058995564221014
R&D to revenue (%): 9.521269713338647
SG&A to revenue (%): 44.3168989252792
Free cash flow (dilution-adjusted): 58963000
Buyback yield (%): 0.7083320435097511
Retained earnings: 2425044000
Inventory turnover: 1.2485415384615384
Receivables turnover: 0.8781606702980259
Capitalized R&D asset: 161522670
ROCI (R&D-adjusted, %): 4.4445167392126494
Rosenberg metric: 0.2881554716515262
FCF margin (%): 5.82379951977828
Revenue growth (%): 3.3889806813702563
Rule of 40 score: 9.212780201148536
Financial ratios for ALGN — quarterly report dated 2025-09-30
Total revenue: 995692000
Gross profit: 639201000
Operating income: 128125000
Net income: 56753000
Capital expenditures: 19761000
Operating cash flow: 188720000
Depreciation & amortization: 55717000
Net tangible assets: 3367226000
Owner earnings: 92709000
Return on net tangible assets (%): 2.753275247934056
Capex to operating income (%): 15.423219512195121
Buffett classification: The Great
Stock price: 125.22
P/E ratio: 32.659562268756076
Shares outstanding: 71618127
Book value: 3957458000
P/B ratio: 2.266106642935945
Market cap (USD): 8968021862.94
Debt to equity: 0.030643660652873637
Current ratio: 1.288653859258182
Quick ratio: 1.1726279528860402
Effective tax rate (%): 40.09225832330525
COGS to revenue (%): 35.8033407921325
R&D to revenue (%): 9.36795715944288
SG&A to revenue (%): 41.9607669841678
Free cash flow (dilution-adjusted): 120582000
Buyback yield (%): 0.7979128629882861
Retained earnings: 2416933000
Inventory turnover: 1.5624537059357209
Receivables turnover: 0.8729836694541814
Capitalized R&D asset: 189938990
ROCI (R&D-adjusted, %): 2.8219720616823376
Rosenberg metric: -0.714911097740617
FCF margin (%): 12.110371480337292
Revenue growth (%): -1.6550957134630977
Rule of 40 score: 10.455275766874195
Financial ratios for ALGN — quarterly report dated 2025-12-31
Total revenue: 1047561000
Gross profit: 683587000
Operating income: 158875000
Net income: 135760000
Capital expenditures: 35916000
Operating cash flow: 223177000
Depreciation & amortization: 101995000
Net tangible assets: 3463381000
Owner earnings: 201839000
Return on net tangible assets (%): 5.827802369996255
Capex to operating income (%): 22.606451612903225
Buffett classification: The Great
Stock price: 156.15
P/E ratio: 27.252694720007995
Shares outstanding: 71618127
Book value: 4049147000
P/B ratio: 2.7618583694417618
Market cap (USD): 11183170531.050001
Debt to equity: 0.028264224539143675
Current ratio: 1.3627820615984771
Quick ratio: 1.24489600341664
Effective tax rate (%): 23.12353124380645
COGS to revenue (%): 34.74489791047968
R&D to revenue (%): 7.926602842221121
SG&A to revenue (%): 42.16231799389248
Free cash flow (dilution-adjusted): 142973000
Buyback yield (%): 0.8695923909055268
Retained earnings: 2464157000
Inventory turnover: 1.608063867669864
Receivables turnover: 0.9049608837778254
Capitalized R&D asset: 177342260
ROCI (R&D-adjusted, %): 3.362435658811005
Rosenberg metric: 0.4758565976242549
FCF margin (%): 13.648178960461491
Revenue growth (%): 5.209341844666825
Rule of 40 score: 18.857520805128317
Financial ratios for ALGN — annual report dated 2025-12-31
Total revenue: 4034964000
Gross profit: 2711013000
Operating income: 585311000
Net income: 410351000
Capital expenditures: 102445000
Operating cash flow: 593223000
Depreciation & amortization: 237436000
Net tangible assets: 3463381000
Owner earnings: 545342000
Return on net tangible assets (%): 15.74594305391177
Capex to operating income (%): 17.50266097852253
Buffett classification: The Great
Stock price: 156.15
P/E ratio: 27.252694720007995
Shares outstanding: 71618127
Book value: 4049147000
P/B ratio: 2.7618583694417618
Market cap (USD): 11183170531.050001
Debt to equity: 0.028264224539143675
Current ratio: 1.3627820615984771
Quick ratio: 1.24489600341664
Effective tax rate (%): 29.888926287445305
COGS to revenue (%): 32.8119656086151
R&D to revenue (%): 9.167640653051675
SG&A to revenue (%): 43.5144154941655
Free cash flow (dilution-adjusted): 304908000
Buyback yield (%): 4.16643025076228
Retained earnings: 2464157000
Inventory turnover: 5.849312768674092
Receivables turnover: 3.4857011548269834
Capitalized R&D asset: 728380240
ROCI (R&D-adjusted, %): 11.798905096873034
Rosenberg metric: -0.24202503006573275
FCF margin (%): 7.556647345552525
Revenue growth (%): 0.8990220584484367
Rule of 40 score: 8.455669404000961
Financial ratios for APGE — annual report dated 2023-12-31
Total revenue: 0
Operating income: -93003000
Net income: -83985000
Capital expenditures: 167000
Operating cash flow: -74761000
Depreciation & amortization: 0
Net tangible assets: 379913000
Owner earnings: -84152000
Return on net tangible assets (%): -22.150334418669537
Buffett classification: The Gruesome
Stock price: 27.94
Shares outstanding: 62140183
Book value: 379913000
P/B ratio: 4.569985004514192
Market cap (USD): 1736196713.02
Debt to equity: 0.005353857330494087
Current ratio: 19.379754839964978
Quick ratio: 19.379754839964978
Free cash flow (dilution-adjusted): -81031000
Buyback yield (%): 0
Retained earnings: -123770000
Receivables turnover: 0
Capitalized R&D asset: 87040620
ROCI (R&D-adjusted, %): -12.107420383168897
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2024-09-30
Capital expenditures: 751000
Buffett classification: The Gruesome
Stock price: 58.74
Shares outstanding: 62140183
Market cap (USD): 3650114349.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APGE — annual report dated 2024-12-31
Total revenue: 0
Operating income: -216870000
Net income: -182146000
Capital expenditures: 1152000
Operating cash flow: -171174000
Depreciation & amortization: 189000
Net tangible assets: 716794000
Owner earnings: -183109000
Return on net tangible assets (%): -25.545554231759755
Buffett classification: The Gruesome
Stock price: 45.3
Shares outstanding: 62140183
Book value: 716794000
P/B ratio: 3.9271398615222783
Market cap (USD): 2814950289.8999996
Debt to equity: 0.01650543949865652
Current ratio: 18.547373949579832
Quick ratio: 18.547373949579832
Free cash flow (dilution-adjusted): -195658000
Buyback yield (%): 0
Retained earnings: -305916000
Receivables turnover: 0
Capitalized R&D asset: 222878460
ROCI (R&D-adjusted, %): -14.450533923131934
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.3
Shares outstanding: 62140183
Market cap (USD): 2814950289.8999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -63096000
Net income: -55339000
Capital expenditures: 4317000
Operating cash flow: -48477000
Depreciation & amortization: 207000
Net tangible assets: 673362000
Owner earnings: -59449000
Return on net tangible assets (%): -8.828683531295201
Buffett classification: The Gruesome
Stock price: 37.36
Shares outstanding: 62140183
Book value: 673362000
P/B ratio: 3.4477104987807445
Market cap (USD): 2321557236.88
Debt to equity: 0.017547767768302934
Current ratio: 15.82314927184466
Quick ratio: 15.82314927184466
Free cash flow (dilution-adjusted): -63920000
Buyback yield (%): 0
Retained earnings: -361255000
Receivables turnover: 0
Capitalized R&D asset: 46387000
ROCI (R&D-adjusted, %): -4.4216354746063145
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -73165000
Net income: -66096000
Capital expenditures: 768000
Operating cash flow: -62029000
Depreciation & amortization: 399000
Net tangible assets: 619401000
Owner earnings: -66465000
Return on net tangible assets (%): -10.730528365307773
Buffett classification: The Gruesome
Stock price: 43.43
Shares outstanding: 62140183
Book value: 619401000
P/B ratio: 4.357029045303447
Market cap (USD): 2698748147.69
Debt to equity: 0.01750885129342704
Current ratio: 16.358340464644545
Quick ratio: 16.358340464644545
Free cash flow (dilution-adjusted): -74141000
Buyback yield (%): 0
Retained earnings: -427351000
Receivables turnover: 0
Capitalized R&D asset: 86782290
ROCI (R&D-adjusted, %): -7.2218460590834015
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -71278000
Net income: -65021000
Capital expenditures: 0
Operating cash flow: -54255000
Depreciation & amortization: 406000
Net tangible assets: 586338000
Owner earnings: -64615000
Return on net tangible assets (%): -11.020094211870969
Buffett classification: The Gruesome
Stock price: 39.73
Shares outstanding: 62140183
Book value: 586338000
P/B ratio: 4.210590940020944
Market cap (USD): 2468829470.5899997
Debt to equity: 0.01680430059112662
Current ratio: 15.863277234411255
Quick ratio: 15.863277234411255
Free cash flow (dilution-adjusted): -66132000
Buyback yield (%): 0
Retained earnings: -492372000
Receivables turnover: 0
Capitalized R&D asset: 106806720
ROCI (R&D-adjusted, %): -9.89948206471467
Rule of 40 score: 0
Financial ratios for APGE — annual report dated 2025-12-31
Total revenue: 0
Operating income: -285595000
Net income: -255843000
Capital expenditures: 5147000
Operating cash flow: -227450000
Depreciation & amortization: 1418000
Net tangible assets: 903883000
Owner earnings: -259572000
Return on net tangible assets (%): -28.717433561644594
Buffett classification: The Gruesome
Stock price: 75.48
Shares outstanding: 62140183
Book value: 903883000
P/B ratio: 5.189101922306317
Market cap (USD): 4690341012.84
Debt to equity: 0.00978998388065712
Current ratio: 26.566258152368665
Quick ratio: 26.566258152368665
Free cash flow (dilution-adjusted): -278874000
Buyback yield (%): 0
Retained earnings: -561759000
Receivables turnover: 0
Capitalized R&D asset: 349761470
ROCI (R&D-adjusted, %): -17.570970364562832
Rule of 40 score: 0
Financial ratios for APGE — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -78056000
Net income: -69387000
Capital expenditures: 62000
Operating cash flow: -62689000
Depreciation & amortization: 406000
Net tangible assets: 903883000
Owner earnings: -69043000
Return on net tangible assets (%): -7.6384886096983795
Buffett classification: The Gruesome
Stock price: 75.48
Shares outstanding: 62140183
Book value: 903883000
P/B ratio: 5.189101922306317
Market cap (USD): 4690341012.84
Debt to equity: 0.00978998388065712
Current ratio: 26.566258152368665
Quick ratio: 26.566258152368665
Free cash flow (dilution-adjusted): -74681000
Buyback yield (%): 0
Retained earnings: -561759000
Receivables turnover: 0
Capitalized R&D asset: 113125250
ROCI (R&D-adjusted, %): -7.406474555965205
Rule of 40 score: 0
Financial ratios for ASPL.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.002837837837837838
Shares outstanding: 289652496
Market cap (USD): 821986.812972973
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASPL.L — annual report dated 2022-12-31
Total revenue: 10701204.81927711
Net income: -19116867.46987952
Capital expenditures: 46987.95180722892
Operating cash flow: -5444578.3132530125
Depreciation & amortization: 72289.15662650602
Net tangible assets: 87506024.09638555
Owner earnings: -19091566.265060242
Return on net tangible assets (%): -21.81743081371334
Buffett classification: The Gruesome
Stock price: 0.0016867469879518076
Shares outstanding: 289652496
Book value: 81691566.26506026
P/B ratio: 0.005980672149135745
Market cap (USD): 488570.475180723
Debt to equity: 0.4846174267004895
COGS to revenue (%): 0
SG&A to revenue (%): 231.23170457104254
Free cash flow (dilution-adjusted): -5491566.265060241
Buyback yield (%): 0
Retained earnings: -147928915.66265061
Receivables turnover: 0.7900026683269591
Capitalized R&D asset: 0
FCF margin (%): -51.31727088493583
Rule of 40 score: -51.31727088493583
Financial ratios for ASPL.L — annual report dated 2023-12-31
Total revenue: 16102531.645569619
Net income: -11053164.556962024
Capital expenditures: 194936.70886075948
Operating cash flow: -6937974.683544303
Depreciation & amortization: 40506.32911392405
Net tangible assets: 79506329.11392404
Owner earnings: -11207594.936708858
Return on net tangible assets (%): -14.096481451998088
Buffett classification: The Gruesome
Stock price: 0.0011392405063291138
Shares outstanding: 289652496
Book value: 71458227.84810127
P/B ratio: 0.004617856699496916
Market cap (USD): 329983.8562025316
Debt to equity: 0.544427123928293
COGS to revenue (%): 0
SG&A to revenue (%): 118.37119723292193
Free cash flow (dilution-adjusted): -7132911.392405063
Buyback yield (%): 0
Retained earnings: -166472151.89873418
Receivables turnover: 1.4375635665046897
Capitalized R&D asset: 0
FCF margin (%): -44.296832010062104
Revenue growth (%): 50.4740065956179
Rule of 40 score: 6.177174585555797
Financial ratios for ASPL.L — annual report dated 2024-12-31
Total revenue: 22450000
Net income: -12375000
Capital expenditures: 178750
Operating cash flow: 6370000
Depreciation & amortization: 72500
Net tangible assets: 52058750
Owner earnings: -12481250
Return on net tangible assets (%): -23.975316349316877
Buffett classification: The Gruesome
Stock price: 0.001125
Shares outstanding: 289652496
Book value: 52108750
P/B ratio: 0.00625344223378991
Market cap (USD): 325859.05799999996
Debt to equity: 0.6743829011442416
COGS to revenue (%): 0
SG&A to revenue (%): 107.71158129175946
Free cash flow (dilution-adjusted): 6191250
Buyback yield (%): 0
Retained earnings: -185410000
Receivables turnover: 8.242312987608996
Capitalized R&D asset: 0
FCF margin (%): 27.57795100222717
Revenue growth (%): 39.419070827765125
Rule of 40 score: 66.99702182999229
Financial ratios for ASPL.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 52058750
Buffett classification: The Gruesome
Stock price: 0.001125
Shares outstanding: 289652496
Book value: 52108750
P/B ratio: 0.00625344223378991
Market cap (USD): 325859.05799999996
Debt to equity: 0.6743829011442416
Buyback yield (%): 0
Retained earnings: -185410000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASTI — annual report dated 2022-12-31
Total revenue: 1222786
Gross profit: -788673
Operating income: -17055535
Net income: -19754705
Capital expenditures: 169357
Operating cash flow: -10506575
Depreciation & amortization: 769874
Net tangible assets: 4505558
Owner earnings: -19154188
Return on net tangible assets (%): -425.12354740522704
Buffett classification: The Gruesome
Stock price: 32600
Shares outstanding: 9816431
Book value: 4585541
P/B ratio: 69787.98152715241
Market cap (USD): 320015650600
Debt to equity: 2.198180977991474
Current ratio: 2.5020171266264937
Quick ratio: 2.3783088064541618
Interest coverage ratio: -6.305400662277363
COGS to revenue (%): 164.49803972240443
R&D to revenue (%): 488.71356067210456
SG&A to revenue (%): 835.4115928707067
Free cash flow (dilution-adjusted): -16167222
Buyback yield (%): 0
Retained earnings: -447537493
Inventory turnover: 3.2691606951597882
Receivables turnover: 691.2300734878462
Capitalized R&D asset: 5975921
ROCI (R&D-adjusted, %): -66.42416575723531
FCF margin (%): -1322.1628314357542
Rule of 40 score: -1322.1628314357542
Financial ratios for ASTI — annual report dated 2023-12-31
Total revenue: 458260
Gross profit: -1434081
Operating income: -12359570
Net income: -17069896
Capital expenditures: 3857783
Operating cash flow: -9536879
Depreciation & amortization: 762764
Net tangible assets: -1580589
Owner earnings: -20164915
Buffett classification: The Gruesome
Stock price: 87
Shares outstanding: 9816431
Book value: -1526611
Market cap (USD): 854029497
Debt to equity: -2.769900780224956
Current ratio: 0.26653187682073476
Quick ratio: 0.1888559879619522
Interest coverage ratio: -5.6848662308117595
COGS to revenue (%): 412.940470475276
R&D to revenue (%): 703.1560686073408
SG&A to revenue (%): 1660.1859206563959
Free cash flow (dilution-adjusted): -15657690
Buyback yield (%): 0.10538277696045432
Retained earnings: -482478436
Inventory turnover: 4.228732770795717
Capitalized R&D asset: 7226150.07
ROCI (R&D-adjusted, %): -157.1829797277066
Rosenberg metric: -0.10800142772971731
FCF margin (%): -3416.7699559202197
Revenue growth (%): -62.52328698562136
Rule of 40 score: -3479.293242905841
Financial ratios for ASTI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 9816431
Market cap (USD): 25130063.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASTI — annual report dated 2024-12-31
Total revenue: 41893
Gross profit: -106483
Operating income: -8012668
Net income: -9130274
Capital expenditures: 421
Operating cash flow: -8423569
Depreciation & amortization: 558442
Net tangible assets: 3351429
Owner earnings: -8572253
Return on net tangible assets (%): -255.77904231299544
Buffett classification: The Gruesome
Stock price: 3.27
Shares outstanding: 9816431
Book value: 3379923
P/B ratio: 9.49717770789453
Market cap (USD): 32099729.37
Debt to equity: 0.6102446712543451
Current ratio: 1.628358283568803
Quick ratio: 1.4296642790801286
Interest coverage ratio: -12.036129412153494
COGS to revenue (%): 354.17850237509845
R&D to revenue (%): 5492.440264483326
SG&A to revenue (%): 13202.909793998999
Free cash flow (dilution-adjusted): -9433782
Buyback yield (%): 0
Retained earnings: -491608710
Inventory turnover: 0.3274663818160551
Capitalized R&D asset: 6431931.540000001
ROCI (R&D-adjusted, %): -84.48231197375684
Rosenberg metric: 0.4120054011395026
FCF margin (%): -22518.75492325687
Revenue growth (%): -90.85824641033474
Rule of 40 score: -22609.613169667206
Financial ratios for ASTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.27
Shares outstanding: 9816431
Market cap (USD): 32099729.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASTI — quarterly report dated 2025-03-31
Total revenue: 15624
Gross profit: -8491
Operating income: -1746430
Net income: -1674296
Capital expenditures: 0
Operating cash flow: -1550030
Depreciation & amortization: 147490
Net tangible assets: 2549009
Owner earnings: -1526806
Return on net tangible assets (%): -59.8980231140808
Buffett classification: The Gruesome
Stock price: 1.41
Shares outstanding: 9816431
Book value: 2577318
P/B ratio: 5.37037637963185
Market cap (USD): 13841167.709999999
Debt to equity: 0.7390989392849466
Current ratio: 1.2476001699488846
Quick ratio: 1.0513920890015678
Interest coverage ratio: -114.51249098419775
COGS to revenue (%): 154.3458781362007
R&D to revenue (%): 3576.190476190476
SG&A to revenue (%): 7439.093701996927
Free cash flow (dilution-adjusted): -1761303
Buyback yield (%): 0
Retained earnings: -493283006
Inventory turnover: 0.053612955148755664
Capitalized R&D asset: 558744
ROCI (R&D-adjusted, %): -30.94946435031611
FCF margin (%): -11273.060675883256
Rule of 40 score: -11273.060675883256
Financial ratios for ASTI — quarterly report dated 2025-06-30
Total revenue: 16961
Gross profit: -11647
Operating income: -2089054
Net income: -2065397
Capital expenditures: 0
Operating cash flow: -1811514
Depreciation & amortization: 152205
Net tangible assets: 3405755
Owner earnings: -1913192
Return on net tangible assets (%): -56.17526803895172
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 9816431
Book value: 3434064
P/B ratio: 7.546562277231875
Market cap (USD): 25915377.84
Debt to equity: 0.5132621290692311
Current ratio: 1.6239793207180107
Quick ratio: 1.4177804897819488
Interest coverage ratio: -171.81133316884612
COGS to revenue (%): 168.66930015918874
R&D to revenue (%): 3672.666705972525
SG&A to revenue (%): 8472.637226578621
Free cash flow (dilution-adjusted): -2215733
Buyback yield (%): 0
Retained earnings: -495348403
Inventory turnover: 0.06247911575278293
Receivables turnover: 1.3229077295062788
Capitalized R&D asset: 997279.48
ROCI (R&D-adjusted, %): -33.4054806812023
Rosenberg metric: -0.005648382801426055
FCF margin (%): -13063.693178468251
Revenue growth (%): 8.557347670250897
Rule of 40 score: -13055.135830798
Financial ratios for ASTI — quarterly report dated 2025-09-30
Total revenue: 28549
Gross profit: -60442
Operating income: -1967683
Net income: -2021640
Capital expenditures: 0
Operating cash flow: -1735538
Depreciation & amortization: 162909
Net tangible assets: 2641585
Owner earnings: -1858731
Return on net tangible assets (%): -70.36423208036085
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 9816431
Book value: 2651058
P/B ratio: 7.257557080984271
Market cap (USD): 19240204.759999998
Debt to equity: 0.6095472071904877
Current ratio: 1.2341668157101944
Quick ratio: 1.0286433012870393
Interest coverage ratio: -160.07834363813862
COGS to revenue (%): 311.7131948579635
R&D to revenue (%): 2173.7083610634345
SG&A to revenue (%): 4423.405373217976
Free cash flow (dilution-adjusted): -2026995
Buyback yield (%): 0
Retained earnings: -497370043
Inventory turnover: 0.2011491524887379
Capitalized R&D asset: 1222314.59
ROCI (R&D-adjusted, %): -40.25790164288417
Rosenberg metric: -0.07833256544569857
FCF margin (%): -7100.056043994536
Revenue growth (%): 68.32144331112552
Rule of 40 score: -7031.7346006834105
Financial ratios for ASTI — quarterly report dated 2025-12-31
Total revenue: 15639
Gross profit: -38978
Operating income: -2071213
Net income: -2071422
Capital expenditures: 0
Operating cash flow: -1806884
Depreciation & amortization: 164997
Net tangible assets: 3328718
Owner earnings: -1906425
Return on net tangible assets (%): -57.27204887887769
Buffett classification: The Gruesome
Stock price: 4.11
Shares outstanding: 9816431
Book value: 3337849
P/B ratio: 12.087284778310822
Market cap (USD): 40345531.410000004
Debt to equity: 0.4388670667846269
Current ratio: 1.5344610991954308
Quick ratio: 1.2880096220062136
Interest coverage ratio: -168.50089489098602
COGS to revenue (%): 349.23588464735593
R&D to revenue (%): 4143.685657650745
SG&A to revenue (%): 8713.645373745125
Free cash flow (dilution-adjusted): -2065673
Buyback yield (%): 0
Retained earnings: -499441465
Inventory turnover: 0.10046963211231437
Capitalized R&D asset: 1269378.17
ROCI (R&D-adjusted, %): -38.06298605826117
Rosenberg metric: 0.03458744513126599
FCF margin (%): -13208.472408721787
Revenue growth (%): -45.22049809100144
Rule of 40 score: -13253.692906812788
Financial ratios for ASTI — annual report dated 2025-12-31
Total revenue: 76773
Gross profit: -119559
Operating income: -7874381
Net income: -7832755
Capital expenditures: 32015
Operating cash flow: -6903966
Depreciation & amortization: 627601
Net tangible assets: 3328718
Owner earnings: -7237169
Return on net tangible assets (%): -217.4161043380665
Buffett classification: The Gruesome
Stock price: 4.11
Shares outstanding: 9816431
Book value: 3337849
P/B ratio: 12.087284778310822
Market cap (USD): 40345531.410000004
Debt to equity: 0.4388670667846269
Current ratio: 1.5344610991954308
Quick ratio: 1.2880096220062136
Interest coverage ratio: -151.44787860137708
COGS to revenue (%): 255.7305302645461
R&D to revenue (%): 3182.360986284241
SG&A to revenue (%): 6814.85287796491
Free cash flow (dilution-adjusted): -8069704
Buyback yield (%): 0
Retained earnings: -499441465
Inventory turnover: 0.36115868341129875
Capitalized R&D asset: 5048182.550000001
ROCI (R&D-adjusted, %): -88.14464824163778
Rosenberg metric: -0.005682875058454167
FCF margin (%): -10511.122399802014
Revenue growth (%): 83.2597331296398
Rule of 40 score: -10427.862666672374
Financial ratios for BZUN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.9
Shares outstanding: 53707409
Market cap (USD): 746532985.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZUN — annual report dated 2022-12-31
Total revenue: 1206987212.6436782
Gross profit: 492087931.0344828
Operating income: 6672701.149425288
Net income: -87697413.79310344
Capital expenditures: 29735057.47126437
Operating cash flow: 54971982.75862069
Depreciation & amortization: 28238936.781609196
Net tangible assets: 488164080.45977014
Owner earnings: -89193534.48275861
Return on net tangible assets (%): -18.271220282891974
Capex to operating income (%): 445.6224968778261
Buffett classification: The Gruesome
Stock price: 5.3
Shares outstanding: 53707409
Book value: 815565804.5977011
P/B ratio: 0.3490206015202055
Market cap (USD): 284649267.7
Debt to equity: 0.42515227246862325
Current ratio: 2.0091890988946517
Quick ratio: 1.7530544091024531
Interest coverage ratio: 0.8159600822249943
COGS to revenue (%): 59.23006259886906
SG&A to revenue (%): 36.257133541516104
Free cash flow (dilution-adjusted): -2732471.264367815
Buyback yield (%): 22.544178525023405
Retained earnings: -32782327.586206898
Inventory turnover: 5.276473838198848
Receivables turnover: 3.040666217840131
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.721056696929353
FCF margin (%): -0.2263877558721481
Rule of 40 score: -0.2263877558721481
Financial ratios for BZUN — annual report dated 2023-12-31
Total revenue: 1239382981.715893
Gross profit: 547903938.1153305
Operating income: -24074261.603375528
Net income: -31332770.745428972
Capital expenditures: 23207735.58368495
Operating cash flow: 63045710.26722925
Depreciation & amortization: 35390717.299578056
Net tangible assets: 483805344.5850914
Owner earnings: -19149789.029535867
Return on net tangible assets (%): -3.9581598764599457
Buffett classification: The Gruesome
Stock price: 2.74
Shares outstanding: 53707409
Book value: 823028973.2770745
P/B ratio: 0.1788008751065667
Market cap (USD): 147158300.66000003
Debt to equity: 0.47070288201655036
Current ratio: 1.940090900382122
Quick ratio: 1.6619836294159596
Interest coverage ratio: -4.140092879256966
COGS to revenue (%): 55.792200942054905
SG&A to revenue (%): 41.81711942549336
Free cash flow (dilution-adjusted): 16118706.047819972
Buyback yield (%): 0
Retained earnings: -71249929.67651196
Inventory turnover: 4.704182119496783
Receivables turnover: 3.310735679548911
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.548464114430756
FCF margin (%): 1.300542793116624
Revenue growth (%): 2.684019245014039
Rule of 40 score: 3.984562038130663
Financial ratios for BZUN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 53707409
Market cap (USD): 192272524.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZUN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.72
Shares outstanding: 53707409
Market cap (USD): 146084152.48000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZUN — annual report dated 2024-12-31
Total revenue: 1290716301.369863
Gross profit: 614634794.520548
Operating income: -14779589.04109589
Net income: -18956712.328767125
Capital expenditures: 18096986.301369864
Operating cash flow: 13873698.630136987
Depreciation & amortization: 33541232.87671233
Net tangible assets: 432449041.0958904
Owner earnings: -3512465.7534246594
Return on net tangible assets (%): -0.812226509861959
Buffett classification: The Gruesome
Stock price: 2.72
Shares outstanding: 53707409
Book value: 791860136.9863013
P/B ratio: 0.1844822660678109
Market cap (USD): 146084152.48000002
Debt to equity: 0.436474962110197
Current ratio: 1.9250330281834271
Quick ratio: 1.6268550418312515
Interest coverage ratio: -2.7673583502193035
COGS to revenue (%): 52.380333783014606
SG&A to revenue (%): 43.512856671176216
Free cash flow (dilution-adjusted): -25103013.69863014
Buyback yield (%): 8.955431189030406
Retained earnings: -94765068.49315068
Inventory turnover: 4.41670194077708
Receivables turnover: 3.919663820659979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6702830769954813
FCF margin (%): -1.9448901103974445
Revenue growth (%): 4.141844805945325
Rule of 40 score: 2.19695469554788
Financial ratios for BZUN — quarterly report dated 2025-03-31
Total revenue: 284347107.43801653
Gross profit: 136729614.32506886
Operating income: -11568870.523415979
Net income: -8688705.23415978
Capital expenditures: 0
Net tangible assets: 426297796.1432507
Owner earnings: -8688705.23415978
Return on net tangible assets (%): -2.038177375714154
Buffett classification: The Gruesome
Stock price: 2.73
Shares outstanding: 53707409
Book value: 785114600.5509641
P/B ratio: 0.18675136912128076
Market cap (USD): 146621226.57
Debt to equity: 0.4241254106189337
Current ratio: 1.9857632455207805
Quick ratio: 1.6501761111055364
Interest coverage ratio: -6.70418263090677
COGS to revenue (%): 51.914540099595044
SG&A to revenue (%): 47.028425274661394
Buyback yield (%): 0
Retained earnings: -103975895.31680441
Inventory turnover: 0.9425401284215027
Receivables turnover: 1.0224665676077265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3266556699089886
Rule of 40 score: 0
Financial ratios for BZUN — quarterly report dated 2025-06-30
Total revenue: 356019665.2719665
Gross profit: 172273919.10739192
Operating income: -1307949.790794979
Net income: -2852719.6652719667
Capital expenditures: 0
Net tangible assets: 425683263.5983264
Owner earnings: -2852719.6652719667
Return on net tangible assets (%): -0.6701507691793552
Buffett classification: The Gruesome
Stock price: 2.5
Shares outstanding: 53707409
Book value: 790320502.0920503
P/B ratio: 0.16989123038637996
Market cap (USD): 134268522.5
Debt to equity: 0.4183139513337632
Current ratio: 1.9696339978404707
Quick ratio: 1.6854344150006422
Interest coverage ratio: -0.7960275019098548
COGS to revenue (%): 51.61112266767894
SG&A to revenue (%): 45.52986080016109
Buyback yield (%): 0
Retained earnings: -110017154.81171548
Inventory turnover: 1.378149317806898
Receivables turnover: 1.0765706607554961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.149864134690431
Revenue growth (%): 25.20600912023469
Rule of 40 score: 25.20600912023469
Financial ratios for BZUN — quarterly report dated 2025-09-30
Total revenue: 302841853.9325843
Gross profit: 158619101.1235955
Operating income: -3597893.258426966
Net income: -13302528.08988764
Capital expenditures: 0
Net tangible assets: 427512921.3483146
Owner earnings: -13302528.08988764
Return on net tangible assets (%): -3.1116084276314666
Buffett classification: The Gruesome
Stock price: 4.05
Shares outstanding: 53707409
Book value: 775511797.752809
P/B ratio: 0.28047930035402496
Market cap (USD): 217515006.45
Debt to equity: 0.4352241832323851
Current ratio: 1.8735586631761707
Quick ratio: 1.5643726593055034
Interest coverage ratio: -2.611847471451876
COGS to revenue (%): 47.62312439187954
SG&A to revenue (%): 48.94918640555709
Buyback yield (%): 0
Retained earnings: -125832584.26966292
Inventory turnover: 0.9184930097764739
Receivables turnover: 1.0928668778164496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4149101376263583
Revenue growth (%): -14.936762355180363
Rule of 40 score: -14.936762355180363
Financial ratios for BZUN — quarterly report dated 2025-12-31
Total revenue: 453175428.5714286
Gross profit: 243212428.57142857
Operating income: 27705000
Net income: -1734857.142857143
Capital expenditures: 0
Net tangible assets: 429850857.14285713
Owner earnings: -1734857.142857143
Return on net tangible assets (%): -0.4035951339933186
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.66
Shares outstanding: 53707409
Book value: 784513142.8571429
P/B ratio: 0.182102376793469
Market cap (USD): 142861707.94
Debt to equity: 0.4137696318298955
Current ratio: 1.8663473028922704
Quick ratio: 1.6250903937381143
Interest coverage ratio: 18.549497847919653
COGS to revenue (%): 46.331505806013936
SG&A to revenue (%): 44.45916245616645
Buyback yield (%): 0
Retained earnings: -133412142.85714285
Inventory turnover: 1.671259840281276
Receivables turnover: 1.293766183659994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2076834218994787
Revenue growth (%): 49.640950445479085
Rule of 40 score: 49.640950445479085
Financial ratios for BZUN — annual report dated 2025-12-31
Total revenue: 1420783285.7142856
Gross profit: 722816571.4285715
Operating income: 10707142.857142856
Net income: -28511428.57142857
Capital expenditures: 15220571.42857143
Operating cash flow: 60062000
Depreciation & amortization: 31677285.714285713
Net tangible assets: 429850857.14285713
Owner earnings: -12054714.285714287
Return on net tangible assets (%): -2.804394613945834
Capex to operating income (%): 142.15343562374917
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 53707409
Book value: 784513142.8571429
P/B ratio: 0.182102376793469
Market cap (USD): 142861707.94
Debt to equity: 0.4137696318298955
Current ratio: 1.8663473028922704
Quick ratio: 1.6250903937381143
Interest coverage ratio: 1.681548954500583
COGS to revenue (%): 49.125487419766344
SG&A to revenue (%): 46.240730590962755
Free cash flow (dilution-adjusted): 35237000
Buyback yield (%): 1.021667352027199
Retained earnings: -133412142.85714285
Inventory turnover: 5.555663328485446
Receivables turnover: 4.0561805726339175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2396724287589447
FCF margin (%): 2.4801108201582567
Revenue growth (%): 10.077116420268334
Rule of 40 score: 12.557227240426592
Financial ratios for CBIO — annual report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -15479000
Buffett classification: The Gruesome
Stock price: 25
Shares outstanding: 36959831
Book value: -15479000
Market cap (USD): 923995775
Debt to equity: -2.421474255442858
Current ratio: 3.620137299771167
Quick ratio: 3.620137299771167
Buyback yield (%): 0
Retained earnings: -17867000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBIO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25
Shares outstanding: 36959831
Market cap (USD): 923995775
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBIO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -14224000
Net income: -15148000
Capital expenditures: 0
Operating cash flow: -10851000
Depreciation & amortization: 0
Owner earnings: -15148000
Buffett classification: The Gruesome
Stock price: 21
Shares outstanding: 36959831
Market cap (USD): 776156451
Interest coverage ratio: -12.79136690647482
Free cash flow (dilution-adjusted): -12080000
Buyback yield (%): 0
Capitalized R&D asset: 10627000
ROCI (R&D-adjusted, %): -67.18107963991092
Rule of 40 score: 0